₹327.70
+1.83%NSE close, 16 Nov 2026
+33.79%
Artemis Medicare Services is a small cap company, listed on NSE under the symbol ARTEMISMED. At ₹327.70 a share, the market values the whole company at ₹5,188 crore.
In FY26, it reported sales of ₹1,081 crore and a net profit of ₹104 crore, an operating margin of 17.4%. Over the last three years, sales grew 13.6% a year and net profit grew 39.0% a year.
The market values the company at 45.2 times its profit over the last twelve months and 5.24 times its book value; its return on equity is 11.6% and its borrowings are 0.24 times its equity.
Promoters hold 58.39% of the shares. Foreign institutions hold 12.46%, and domestic institutions, mutual funds among them, 1.91%.
Over the past year the share price has risen 34.7%, and it is 13.5% below its 52-week high.
₹ crore. Consolidated figures.
Analysts/ Institutional Investors Conference - November 17, 2026
Transcript of Earnings Conference Call - Q2 and H1 FY27
Audio Recording of Earnings Conference Call - Q2 and H1 FY27
Monitoring Agency Report for the quarter ended September 30, 2026
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 219 | 225 | 223 | 241 | 232 | 240 | 255 | 275 | 272 | 279 | 287 | 311 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 186 | 187 | 187 | 199 | 195 | 204 | 214 | 224 | 228 | 228 | 231 | 256 |
| Operating profit | 32.6 | 38.0 | 36.2 | 42.3 | 37.5 | 35.9 | 41.4 | 50.6 | 44.6 | 51.6 | 56.4 | 54.8 |
| Operating margin | 14.9% | 16.8% | 16.2% | 17.5% | 16.1% | 15.0% | 16.2% | 18.4% | 16.4% | 18.5% | 19.6% | 17.6% |
| Other income | 1.8 | 1.9 | 4.4 | 7.4 | 8.8 | 12.4 | 6.9 | 7.7 | 7.5 | 7.8 | 5.4 | 8.1 |
| Interest | 8.0 | 8.6 | 8.1 | 8.0 | 8.0 | 7.8 | 7.4 | 7.2 | 6.8 | 6.4 | 6.5 | 7.4 |
| Depreciation | 10.2 | 11.0 | 10.8 | 11.2 | 11.5 | 11.7 | 11.2 | 11.7 | 12.4 | 12.8 | 12.7 | 14.5 |
| Profit before tax | 16.3 | 20.2 | 21.6 | 30.6 | 26.8 | 28.7 | 29.8 | 39.4 | 29.8 | 40.3 | 42.6 | 41.0 |
| Tax | 4.8 | 5.9 | 5.1 | 8.4 | 6.2 | 5.7 | 8.6 | 9.4 | 7.5 | 10.0 | 11.2 | 9.9 |
| Net profit | 11.6 | 14.2 | 16.7 | 22.3 | 20.7 | 23.0 | 21.3 | 30.0 | 22.3 | 30.0 | 31.3 | 31.0 |
| EPS (₹) | 0.85 | 1.04 | 1.14 | 1.42 | 1.32 | 1.47 | 1.35 | 1.90 | 1.41 | 1.90 | 1.98 | 1.96 |
₹ crore, financial years to March.
| Line | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Sales | 565 | 408 | 555 | 737 | 879 | 937 | 1,081 |
| Expenses | 504 | 373 | 487 | 643 | 746 | 785 | 893 |
| Operating profit | 61.5 | 35.2 | 67.5 | 94.0 | 133 | 152 | 188 |
| Operating margin | 10.9% | 8.6% | 12.2% | 12.7% | 15.1% | 16.2% | 17.4% |
| Other income | 4.6 | 3.5 | 3.9 | 7.3 | 7.4 | 33.0 | 29.8 |
| Interest | 12.8 | 12.9 | 12.0 | 19.7 | 31.3 | 31.9 | 27.7 |
| Depreciation | 22.6 | 21.5 | 22.2 | 31.0 | 40.3 | 45.2 | 48.1 |
| Profit before tax | 30.6 | 7.5 | 37.2 | 50.6 | 68.5 | 108 | 139 |
| Tax | 11.2 | 1.4 | 5.8 | 12.6 | 19.3 | 25.5 | 35.5 |
| Net profit | 19.8 | 6.2 | 31.8 | 38.6 | 49.1 | 82.6 | 104 |
| EPS (₹) | 14.95 | 4.90 | 2.40 | 2.89 | 3.61 | 5.37 | 6.56 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 59.6 | 146 | 132 | 112 |
| From investing | −107 | −385 | −90.0 | −121 |
| From financing | 44.2 | 267 | −50.1 | −5.9 |
| Spent on fixed assets | −109 | −93.2 | −105 | −112 |
| Free cash flow | −49.3 | 52.5 | 27.0 | −0.0 |
Margins, returns, debt, tax and cash.
| Line | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Net margin | 3.5% | 1.5% | 5.7% | 5.2% | 5.6% | 8.8% | 9.6% |
| Operating margin | 10.9% | 8.6% | 12.2% | 12.7% | 15.1% | 16.2% | 17.4% |
| Return on equity | – | – | – | 9.6% | 11.0% | 9.9% | 11.1% |
| Return on capital employed | – | – | – | 10.9% | 14.2% | 12.9% | 14.4% |
| Return on assets | – | – | – | 4.3% | 5.1% | 6.1% | 7.3% |
| Debt to equity | – | – | – | 0.60 | 0.57 | 0.29 | 0.24 |
| Interest coverage | 3.40 | 1.60 | 4.10 | 3.60 | 3.20 | 4.40 | 6.00 |
| Debt to assets | – | – | – | 0.27 | 0.26 | 0.18 | 0.16 |
| Current ratio | – | – | – | 0.83 | 0.98 | 2.49 | 1.74 |
| Quick ratio | – | – | – | 0.76 | 0.92 | 2.45 | 1.68 |
| Cash ratio | – | – | – | 0.11 | 0.08 | 0.19 | 0.16 |
| Asset turnover | – | – | – | 0.81 | 0.90 | 0.69 | 0.76 |
| Fixed asset turnover | – | – | – | 1.43 | 1.44 | 1.43 | 1.50 |
| Inventory turnover | – | – | – | – | 21.70 | 22.80 | 18.90 |
| Receivables turnover | – | – | – | 7.90 | 9.30 | 9.20 | 9.00 |
| Gross margin | – | – | – | – | 75.1% | 75.7% | 76.5% |
| Cash from operations to profit | – | – | 187.0% | – | – | 176.0% | 127.0% |
| Effective tax rate | 36.5% | 18.2% | 15.5% | 24.9% | 28.2% | 23.7% | 25.5% |
Artemis Consolidated Revenue from Operations up 13.2% in Q2 FY27 (YoY); Adj. EBITDA* up 22.7%; EBITDA up 7.9%; Net Profit up 3.7%
The financial results for the period ended September 30, 2026.
Schedule of Earnings Conference Call - Q2 and H1 FY27
A disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
A disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Monitoring Agency Report for the quarter ended June 30, 2026
Artemis Consolidated Revenue from Operations up 12.7% in Q1 FY27 (YoY); EBITDA up 27.9%; Profit up 48.3%
Proposed capacity expansion by adding 200+ beds through Tower IV in the Company s flagship Hospital located at Sector-51, Gurugram